-
EP1673352
European procedure
Extract from the Register of European Patents
EP About this file: EP1673352
| EP1673352 - SULFOXIMINE-SUBSTITUTED PYRIMIDINES FOR USE AS CD AND/OR VEGF-INHIBITORS, THE PRODUCTION THEREOF AND THEIR USE AS DRUGS [Right-click to bookmark this link] | |||
| Former [2006/26] | SULFOXIMINE-SUBSTITUTED PYRIMIDINES FOR USE AS CDK AND/OR VEGF INHIBITORS, THE PRODUCTION THEREOF AND THEIR USE AS DRUGS | ||
| [2009/01] | Status | No opposition filed within time limit Status updated on 12.02.2010 Database last updated on 14.11.2024 | Most recent event Tooltip | 12.02.2010 | No opposition filed within time limit | published on 17.03.2010 [2010/11] | Applicant(s) | For all designated states Bayer Schering Pharma Aktiengesellschaft Müllerstrasse 178 13353 Berlin / DE | [2007/19] |
| Former [2007/15] | For all designated states Bayer Schering Pharma AG Müllerstrasse 178 13353 Berlin / DE | ||
| Former [2006/26] | For all designated states Schering Aktiengesellschaft Müllerstrasse 178 13342 Berlin / DE | Inventor(s) | 01 /
LÜCKING, Ulrich Bödikerstrasse 6 10245 Berlin / DE | 02 /
KRÜGER, Martin Heeruferweg 7A 13465 Berlin / DE | 03 /
JAUTELAT, Rolf Driesener Strasse 1 10439 Berlin / DE | 04 /
SIEMEISTER, Gerhard Reimerswalder Steig 26 13503 Berlin / DE | [2006/30] |
| Former [2006/26] | 01 /
LÜCKING, Ulrich Bergstrasse 62 10115 Berlin / DE | ||
| 02 /
KRÜGER, Martin Heeruferweg 7A 13465 Berlin / DE | |||
| 03 /
JAUTELAT, Rolf Driesener Strasse 1 10439 Berlin / DE | |||
| 04 /
SIEMEISTER, Gerhard Reimerswalder Steig 26 13503 Berlin / DE | Application number, filing date | 04790500.5 | 12.10.2004 | [2006/26] | WO2004EP11661 | Priority number, date | DE2003149423 | 16.10.2003 Original published format: DE 10349423 | [2006/26] | Filing language | DE | Procedural language | DE | Publication | Type: | A1 Application with search report | No.: | WO2005037800 | Date: | 28.04.2005 | Language: | DE | [2005/17] | Type: | A1 Application with search report | No.: | EP1673352 | Date: | 28.06.2006 | Language: | DE | The application published by WIPO in one of the EPO official languages on 28.04.2005 takes the place of the publication of the European patent application. | [2006/26] | Type: | B1 Patent specification | No.: | EP1673352 | Date: | 08.04.2009 | Language: | DE | [2009/15] | Search report(s) | International search report - published on: | EP | 28.04.2005 | Classification | IPC: | C07D239/48, C07D239/47 | [2006/26] | CPC: |
C07D239/47 (EP,KR,US);
C07D239/48 (EP,KR,US);
A61K31/505 (KR);
A61P1/04 (EP);
A61P1/16 (EP);
A61P13/12 (EP);
A61P15/00 (EP);
A61P17/00 (EP);
A61P17/06 (EP);
A61P17/12 (EP);
A61P17/14 (EP);
A61P19/02 (EP);
A61P25/00 (EP);
A61P25/14 (EP);
A61P25/16 (EP);
A61P25/28 (EP);
A61P27/02 (EP);
A61P29/00 (EP);
A61P31/00 (EP);
A61P31/12 (EP);
A61P31/14 (EP);
A61P31/18 (EP);
A61P31/22 (EP);
A61P33/00 (EP);
A61P35/00 (EP);
A61P35/02 (EP);
A61P35/04 (EP);
A61P37/00 (EP);
A61P37/06 (EP);
A61P43/00 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2006/26] | Extension states | AL | 31.03.2006 | HR | 31.03.2006 | LT | 31.03.2006 | LV | 31.03.2006 | MK | 31.03.2006 | Title | German: | SULFOXIMINSUBSTITUIERTE PYRIMIDINE ALS CDK- UND/ODER VEGF-INHITOREN, DEREN HERSTELLUNG UND VERWENDUNG ALS ARZNEIMITTEL | [2009/01] | English: | SULFOXIMINE-SUBSTITUTED PYRIMIDINES FOR USE AS CD AND/OR VEGF-INHIBITORS, THE PRODUCTION THEREOF AND THEIR USE AS DRUGS | [2009/03] | French: | PYRIMIDINES SUBSTITUEES SULFOXIMINE EN TANT QU'INHIBITEURS DE CDK ET/OU VEGF, LEUR PRODUCTION ET LEUR UTILISATION COMME MEDICAMENTS | [2009/03] |
| Former [2006/26] | SULFOXIMINSUBSTITUIERTE PYRIMIDINE ALS CDK- UND/ODER VEGF-INHIBITOREN, DEREN HERSTELLUNG UND VERWENDUNG ALS ARZNEIMITTEL | ||
| Former [2006/26] | SULFOXIMINE-SUBSTITUTED PYRIMIDINES FOR USE AS CDK AND/OR VEGF INHIBITORS, THE PRODUCTION THEREOF AND THEIR USE AS DRUGS | ||
| Former [2006/26] | PYRIMIDINES SUBSTITUEES SULFOXIMINE EN TANT QU'INHIBITEURS DE CDK ET/OU VEGF, LEUR PRODUCTION ET LEUR UTILISATION COMME MEDICAMENTS | Entry into regional phase | 31.03.2006 | National basic fee paid | 31.03.2006 | Designation fee(s) paid | 31.03.2006 | Examination fee paid | Examination procedure | 31.03.2006 | Examination requested [2006/26] | 22.12.2006 | Despatch of a communication from the examining division (Time limit: M04) | 02.04.2007 | Reply to a communication from the examining division | 22.12.2008 | Communication of intention to grant the patent | 13.02.2009 | Fee for grant paid | 13.02.2009 | Fee for publishing/printing paid | Opposition(s) | 11.01.2010 | No opposition filed within time limit [2010/11] | Fees paid | Renewal fee | 15.12.2006 | Renewal fee patent year 03 | 17.09.2007 | Renewal fee patent year 04 | 17.09.2008 | Renewal fee patent year 05 | Penalty fee | Additional fee for renewal fee | 31.10.2006 | 03 M06 Fee paid on 15.12.2006 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [DA]WO02096888 (SCHERING AG [DE]) [DA] 1-28 * page 1, line 4 - line 6 * * Seite 2, Formel (I) * * page 3, line 17 - line 19 * * page 23, line 18 - line 31 ** examples 233-237 *; | [DA]WO03076437 (SCHERING AG [DE]) [DA] 1-28 * page 1, line 4 - line 6 * * Seite 1, Formel (I) * * page 3, line 23 - line 25 * * page 26, line 9 - line 22 * * example - * |